Pharmacokinetics of Vancomycin in Adults Receiving ECMO
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
1. Vancomycin is a drug that requires precise dosing and close monitoring to avoid drug
toxicity.
2. There is limited data on the change of vancomycin pharmacokinetics in patients who need
extracorporeal membrane oxygenation (ECMO).
3. This control trial is to understand:
1. whether the pharmacokinetics of vancomycin is influenced by the use ECMO
2. design the most appropriate dose of vancomycin in adult patients using ECMO.